These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10308905)

  • 21. Clinical pharmacy: data for a cost-effectiveness evaluation.
    Sita MJ
    Cost Containment; 1982 May; 4(10):3-6. PubMed ID: 10309595
    [No Abstract]   [Full Text] [Related]  

  • 22. Developing drug-use profiles from drug-charge records.
    Hlynka JN; Smith WE; Brodie DC
    Am J Hosp Pharm; 1979 Oct; 36(10):1347-51. PubMed ID: 507077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. As hospital drug budgets soar, pharmacy's role is being rewritten.
    Lumsdon K
    Hospitals; 1992 May; 66(10):34, 36, 38-40. PubMed ID: 1577448
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintaining current hospital formularies throughout the institution.
    Puglisi RC
    Hosp Pharm; 1978 Mar; 13(3):137, 140. PubMed ID: 10306925
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of formulary inclusion costs.
    Myers CE; Pierpaoli P; Smith MA
    Hosp Formul; 1981 Sep; 16(9):951-3, 957-8, 967-8 passim. PubMed ID: 10252372
    [No Abstract]   [Full Text] [Related]  

  • 26. How a small hospital can survive & even prosper under DRGs.
    Schechter G
    Pharm Times; 1986 Feb; 52(2):113-4. PubMed ID: 10275977
    [No Abstract]   [Full Text] [Related]  

  • 27. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedure for evaluating nonformulary drug orders.
    Jay GT; Quercia RA; Gousse G; Chow MS; Quintiliani R
    Am J Hosp Pharm; 1993 Dec; 50(12):2554-6. PubMed ID: 8122692
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-benefit analysis of clinical pharmacy services in a community hospital.
    Meisel S
    Hosp Pharm; 1985 Dec; 20(12):904-6. PubMed ID: 10311347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three surefire ways to cut your pharmacy costs.
    Capitation Manag Rep; 2001 Jan; 8(1):1-7. PubMed ID: 11209215
    [No Abstract]   [Full Text] [Related]  

  • 32. An integrated drug use evaluation program.
    Lazor-Bajcar J; Fowler R
    Dimens Health Serv; 1990 Nov; 67(8):17-20. PubMed ID: 2276521
    [No Abstract]   [Full Text] [Related]  

  • 33. Prescriptions for reducing hospital drug expenditures.
    Stolar MH
    HBI Rep; 1980; 2(3):4-7. PubMed ID: 10247514
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of control programs on cefazolin prescribing in a teaching hospital.
    Ma MY; Goldstein EJ; Meyer RD
    Am J Hosp Pharm; 1979 Aug; 36(8):1055-8. PubMed ID: 484564
    [No Abstract]   [Full Text] [Related]  

  • 35. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality and productivity assessment of clinical pharmacy interventions.
    Baciewicz AM; Cowan RI; Michaels PE; Kyllonen KS
    Hosp Formul; 1994 Nov; 29(11):773, 777-9. PubMed ID: 10138574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomics and the formulary decision-making process.
    Bakst A
    Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solving problems revealed in drug use reviews.
    Fritz WL; Trinca CE; Denny WF
    Am J Hosp Pharm; 1978 Jun; 35(6):653. PubMed ID: 665669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.